Enoxaparine Becat 4 000 IU (40 mg)/0,4 ml inj. sol. s.c./i.v. pre-filled syr. Belgia - englanti - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

enoxaparine becat 4 000 iu (40 mg)/0,4 ml inj. sol. s.c./i.v. pre-filled syr.

laboratorios farmaceuticos rovi s.a. - enoxaparin sodium 10000 - solution for injection in pre-filled syringe - 4000 iu (40 mg)/0,4 ml - enoxaparin sodium 10000 iu/ml - enoxaparin

Enoxaparine Becat 6 000 IU (60 mg)/0,6 ml inj. sol. s.c./i.v. pre-filled syr. Belgia - englanti - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

enoxaparine becat 6 000 iu (60 mg)/0,6 ml inj. sol. s.c./i.v. pre-filled syr.

laboratorios farmaceuticos rovi s.a. - enoxaparin sodium 10000 - solution for injection in pre-filled syringe - 6000 iu (60 mg)/0,6 ml - enoxaparin sodium 10000 iu/ml - enoxaparin

Enoxaparine Becat 8 000 IU (80 mg)/0,8 ml inj. sol. s.c./i.v. pre-filled syr. Belgia - englanti - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

enoxaparine becat 8 000 iu (80 mg)/0,8 ml inj. sol. s.c./i.v. pre-filled syr.

laboratorios farmaceuticos rovi s.a. - enoxaparin sodium 10000 - solution for injection in pre-filled syringe - 8000 iu (80 mg)/0,8 ml - enoxaparin sodium 10000 iu/ml - enoxaparin

Enoxaparine Becat 10 000 IU (100 mg)/1 ml inj. sol. s.c./i.v. pre-filled syr. Belgia - englanti - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

enoxaparine becat 10 000 iu (100 mg)/1 ml inj. sol. s.c./i.v. pre-filled syr.

laboratorios farmaceuticos rovi s.a. - enoxaparin sodium 10000 - solution for injection in pre-filled syringe - 10000 iu (100 mg)/1 ml - enoxaparin sodium 10000 iu/ml - enoxaparin

Enoxaparine Becat 12 000 IU (120 mg)/0,8 ml inj. sol. s.c./i.v. pre-filled syr. Belgia - englanti - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

enoxaparine becat 12 000 iu (120 mg)/0,8 ml inj. sol. s.c./i.v. pre-filled syr.

laboratorios farmaceuticos rovi s.a. - enoxaparin sodium 15000 - solution for injection in pre-filled syringe - 12000 iu (120 mg)/0,8 ml - enoxaparin sodium 15000 iu/ml - enoxaparin

Enoxaparine Becat 15 000 IU (150 mg)/1 ml inj. sol. s.c./i.v. pre-filled syr. Belgia - englanti - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

enoxaparine becat 15 000 iu (150 mg)/1 ml inj. sol. s.c./i.v. pre-filled syr.

laboratorios farmaceuticos rovi s.a. - enoxaparin sodium 15000 - solution for injection in pre-filled syringe - 15000 iu (150 mg)/1 ml - enoxaparin sodium 15000 iu/ml - enoxaparin

CRUSIA Israel - englanti - Ministry of Health

crusia

tzamal bio-pharma ltd - enoxaparin sodium - solution for injection - enoxaparin sodium 100 mg / 1 ml - enoxaparin - crusia is indicated in adults for:•prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery.•prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism.•treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), excluding pe ikely to require thrombolytic therapy or surgery. prevention of thrombus formation in extra corporeal circulation during haemodialysis.•acute coronary syndrome:-treatment of unstable angina and non st-segment elevation myocardial infarction (nstemi), in combination with oral acetylsalicylic acid.-treatment of acute st-segment elevation myocardial infarction (stemi) including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).

EXARANE enoxaparin sodium 100mg/1mL solution for injection prefilled syringe Australia - englanti - Department of Health (Therapeutic Goods Administration)

exarane enoxaparin sodium 100mg/1ml solution for injection prefilled syringe

juno pharmaceuticals pty ltd - enoxaparin sodium, quantity: 100 mg - injection, solution - excipient ingredients: water for injections - ? prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.,? prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.,? prevention of thrombosis in extra-corporeal circulation during haemodialysis.,? treatment of established deep vein thrombosis.,? treatment of unstable angina and non-q-wave myocardial infarction, administered concurrently with aspirin.,? treatment of acute st-segment elevation myocardial infarction (stemi) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).

EXARANE enoxaparin sodium 20mg/0.2mL solution for injection prefilled syringe Australia - englanti - Department of Health (Therapeutic Goods Administration)

exarane enoxaparin sodium 20mg/0.2ml solution for injection prefilled syringe

juno pharmaceuticals pty ltd - enoxaparin sodium, quantity: 20 mg - injection, solution - excipient ingredients: water for injections - ? prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.,? prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.,? prevention of thrombosis in extra-corporeal circulation during haemodialysis.,? treatment of established deep vein thrombosis.,? treatment of unstable angina and non-q-wave myocardial infarction, administered concurrently with aspirin.,? treatment of acute st-segment elevation myocardial infarction (stemi) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).

EXARANE enoxaparin sodium 40mg/0.4mL solution for injection prefilled syringe Australia - englanti - Department of Health (Therapeutic Goods Administration)

exarane enoxaparin sodium 40mg/0.4ml solution for injection prefilled syringe

juno pharmaceuticals pty ltd - enoxaparin sodium, quantity: 40 mg - injection, solution - excipient ingredients: water for injections - ? prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery.,? prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness.,? prevention of thrombosis in extra-corporeal circulation during haemodialysis.,? treatment of established deep vein thrombosis.,? treatment of unstable angina and non-q-wave myocardial infarction, administered concurrently with aspirin.,? treatment of acute st-segment elevation myocardial infarction (stemi) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).